ESR2 and breast carcinoma: We hypothesized that the ERβ/ESR2 mRNA expression levels in ERα+ human breast cancer samples would negatively correlate with those of genes with promoters that contain ERE-AP1 response elements and that there would be a positive association between ESR2 mRNA expression levels and overall survival.